Literature DB >> 22430443

Occupational solvent exposure, genetic variation of DNA repair genes, and the risk of non-Hodgkin's lymphoma.

Jie Jiao1, Tongzhang Zheng, Qing Lan, Yingtai Chen, Qian Deng, Xiaofeng Bi, Christopher Kim, Theodore Holford, Brian Leaderer, Peter Boyle, Yue Ba, Zhaolin Xia, Stephen J Chanock, Nathaniel Rothman, Yawei Zhang.   

Abstract

The main objective of this study was to test the hypothesis that genetic variations in DNA repair genes may modify the association between occupational exposure to solvents and the risk of non-Hodgkin's lymphoma (NHL). A population-based case-control study was conducted on Connecticut women including 518 histologically confirmed incident NHL cases and 597 controls. Unconditional logistic regression models were used to estimate the odds ratios and effect modification from the 30 single nucleotide polymorphisms in 16 DNA repair genes of the association between solvent exposure and the risk of NHL overall and subtypes. Single nucleotide polymorphisms in MGMT (rs12917) and NBS1 (rs1805794) significantly modified the association between exposure to chlorinated solvents and the risk of NHL (Pfor interaction=0.0003 and 0.0048, respectively). After stratification by major NHL histological subtypes, MGMT (rs12917) modified the association between chlorinated solvents and the risk of diffuse large B-cell lymphoma (Pfor interaction=0.0027) and follicular lymphoma (Pfor interaction=0.0024). A significant interaction was also observed between occupational exposure to benzene and BRCA2 (rs144848) for NHL overall (Pfor interaction=0.0042). Our study results suggest that genetic variations in DNA repair genes modify the association between occupational exposure to solvents and the risk of NHL.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22430443      PMCID: PMC3397155          DOI: 10.1097/CEJ.0b013e328351c762

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  36 in total

1.  Occupational risk factors for subgroups of non-Hodgkin's lymphoma.

Authors:  L Tatham; P Tolbert; C Kjeldsberg
Journal:  Epidemiology       Date:  1997-09       Impact factor: 4.822

2.  High incidence of nitrosamine-induced tumorigenesis in mice lacking DNA repair methyltransferase.

Authors:  T Iwakuma; K Sakumi; Y Nakatsuru; H Kawate; H Igarashi; A Shiraishi; T Tsuzuki; T Ishikawa; M Sekiguchi
Journal:  Carcinogenesis       Date:  1997-08       Impact factor: 4.944

3.  BRCA2 associates with acetyltransferase activity when bound to P/CAF.

Authors:  F Fuks; J Milner; T Kouzarides
Journal:  Oncogene       Date:  1998-11-12       Impact factor: 9.867

4.  Genetic polymorphism of human O6-alkylguanine-DNA alkyltransferase: identification of a missense variation in the active site region.

Authors:  C Deng; D Xie; H Capasso; Y Zhao; L D Wang; J Y Hong
Journal:  Pharmacogenetics       Date:  1999-02

5.  Exposure to phenoxyacetic acids, chlorophenols, or organic solvents in relation to histopathology, stage, and anatomical localization of non-Hodgkin's lymphoma.

Authors:  L Hardell; M Eriksson; A Degerman
Journal:  Cancer Res       Date:  1994-05-01       Impact factor: 12.701

6.  Occupational exposure to chlorinated aliphatic hydrocarbons: job exposure matrix.

Authors:  M R Gomez; P Cocco; M Dosemeci; P A Stewart
Journal:  Am J Ind Med       Date:  1994-08       Impact factor: 2.214

7.  Risk of non-Hodgkin lymphoma associated with occupational exposure to solvents, metals, organic dusts and PCBs (Australia).

Authors:  Lin Fritschi; Geza Benke; Ann M Hughes; Anne Kricker; Claire M Vajdic; Andrew Grulich; Jennifer Turner; Samuel Milliken; John Kaldor; Bruce K Armstrong
Journal:  Cancer Causes Control       Date:  2005-06       Impact factor: 2.506

8.  Reduced O6-methylguanine repair in fibroblast cultures from patients with lung cancer.

Authors:  H W Rüdiger; U Schwartz; E Serrand; M Stief; T Krause; D Nowak; G Doerjer; G Lehnert
Journal:  Cancer Res       Date:  1989-10-15       Impact factor: 12.701

9.  Primary immunodeficiencies: genetic risk factors for lymphoma.

Authors:  A H Filipovich; A Mathur; D Kamat; R S Shapiro
Journal:  Cancer Res       Date:  1992-10-01       Impact factor: 12.701

10.  Fine localization of the Nijmegen breakage syndrome gene to 8q21: evidence for a common founder haplotype.

Authors:  K M Cerosaletti; E Lange; H M Stringham; C M Weemaes; D Smeets; B Sölder; B H Belohradsky; A M Taylor; P Karnes; A Elliott; K Komatsu; R A Gatti; M Boehnke; P Concannon
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

View more
  9 in total

1.  Impact of rs12917 MGMT Polymorphism on [18F]FDG-PET Response in Pediatric Hodgkin Lymphoma (PHL).

Authors:  Stefanie Kewitz-Hempel; Lars Kurch; Michaela Cepelova; Ines Volkmer; Axel Sauerbrey; Elke Conrad; Stephanie Knirsch; Gabriele Pöpperl; Daniel Steinbach; Ambros J Beer; Christof M Kramm; Carsten-Oliver Sahlmann; Bernhard Erdlenbruch; Wolf-Dieter Reinbold; Andreas Odparlik; Osama Sabri; Regine Kluge; Martin S Staege
Journal:  Mol Imaging Biol       Date:  2019-12       Impact factor: 3.488

2.  Medical history, lifestyle, family history, and occupational risk factors for follicular lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Authors:  Martha S Linet; Claire M Vajdic; Lindsay M Morton; Anneclaire J de Roos; Christine F Skibola; Paolo Boffetta; James R Cerhan; Christopher R Flowers; Silvia de Sanjosé; Alain Monnereau; Pierluigi Cocco; Jennifer L Kelly; Alexandra G Smith; Dennis D Weisenburger; Christina A Clarke; Aaron Blair; Leslie Bernstein; Tongzhang Zheng; Lucia Miligi; Jacqueline Clavel; Yolanda Benavente; Brian C H Chiu
Journal:  J Natl Cancer Inst Monogr       Date:  2014-08

3.  Polymorphisms in DNA repair genes, hair dye use, and the risk of non-Hodgkin lymphoma.

Authors:  Huan Guo; Bryan A Bassig; Qing Lan; Yong Zhu; Yawei Zhang; Theodore R Holford; Brian Leaderer; Peter Boyle; Qin Qin; Cairong Zhu; Ni Li; Nathaniel Rothman; Tongzhang Zheng
Journal:  Cancer Causes Control       Date:  2014-09-02       Impact factor: 2.506

4.  NBS1 Glu185Gln polymorphism and cancer risk: update on current evidence.

Authors:  Ya-Zhou He; Xiao-Sa Chi; Yuan-Chuan Zhang; Xiang-Bing Deng; Jia-Rong Wang; Wen-Yu Lv; Yan-Hong Zhou; Zi-Qiang Wang
Journal:  Tumour Biol       Date:  2013-08-27

Review 5.  Linking Environmental Exposures to Molecular Pathogenesis in Non-Hodgkin Lymphoma Subtypes.

Authors:  Leah Moubadder; Lauren E McCullough; Christopher R Flowers; Jean L Koff
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-07-29       Impact factor: 4.254

6.  SNP variants associated with non-Hodgkin lymphoma (NHL) correlate with human leukocyte antigen (HLA) class II expression.

Authors:  Lik-Chin Ten; Yoon-Ming Chin; Mei-Chee Tai; Edmund Fui-Min Chin; Yat-Yuen Lim; Sujatha Suthandiram; Kian-Meng Chang; Tee-Chuan Ong; Ping-Chong Bee; Zahurin Mohamed; Gin-Gin Gan; Ching-Ching Ng
Journal:  Sci Rep       Date:  2017-01-31       Impact factor: 4.379

7.  Benzene-Induced Aberrant miRNA Expression Profile in Hematopoietic Progenitor Cells in C57BL/6 Mice.

Authors:  Haiyan Wei; Juan Zhang; Kehong Tan; Rongli Sun; Lihong Yin; Yuepu Pu
Journal:  Int J Mol Sci       Date:  2015-11-12       Impact factor: 5.923

8.  Expanding primary cells from mucoepidermoid and other salivary gland neoplasms for genetic and chemosensitivity testing.

Authors:  Ahmad M Alamri; Xuefeng Liu; Jan K Blancato; Bassem R Haddad; Weisheng Wang; Xiaogang Zhong; Sujata Choudhary; Ewa Krawczyk; Bhaskar V Kallakury; Bruce J Davidson; Priscilla A Furth
Journal:  Dis Model Mech       Date:  2018-01-29       Impact factor: 5.758

9.  Association of ERCC2 Gene Polymorphisms with Susceptibility to Diffuse Large B-Cell Lymphoma.

Authors:  Yong Tong; Yinzhou Xiang; Bao Li; Shijie Bao; Ying Zhou; Wen Yuan; Yu Ling; Dan Hao; Huamin Zhu; Zhiqiang Sun
Journal:  Med Sci Monit       Date:  2018-10-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.